European attempts for the standardisation of the antiphospholipid antibodies
- 11 August 2009
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 18 (10), 913-919
- https://doi.org/10.1177/0961203309106919
Abstract
According to the Sydney criteria, antiphospholipid syndrome (APS) diagnosis is closely related to the demonstration of antiphospholipid antibodies (aPL) in patients sera. For this purpose, three different assays are conventionally accepted: lupus anticoagulant (LA), anticardiolipin (aCL) and anti-β2 glycoprotein I (β2GPI) antibodies. LA, described in the 1950s is a coagulation-based functional assay, which indirectly detects the presence of aPL. The aCL ELISA was developed in 1985; the identification of β2GPI as a major target of aPL, allowed the introduction of anti-β2GPI ELISA. Even if the diagnostic criteria for APS have been well defined, the laboratory detection of aPL is not always reproducible for many reasons. To achieve a univocal diagnostic definition of APS, efforts were made to reduce the inter- and/or intra-laboratory variability of the diagnostic tests. In this article, we analyse the studies performed to standardise aPL assays that were developed within the European Forum on Antiphospholipid Antibodies.Keywords
This publication has 54 references indexed in Scilit:
- Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein CBlood Coagulation & Fibrinolysis, 2008
- Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2006
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Antigenic structures recognized by anti-β2-glycoprotein I auto-antibodiesInternational Immunology, 2005
- Variability of anti-β2 glycoprotein I antibodies measurement by commercial assaysThrombosis and Haemostasis, 2005
- Heterogeneity of anti-β2-glycoprotein I antibodiesThrombosis and Haemostasis, 2005
- Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UK NEQAS proficiency testing programmeJournal of Thrombosis and Haemostasis, 2004
- Consensus guidelines on anti-cardiolipin antibody testing and reportingPathology, 2004
- Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methodsBritish Journal of Haematology, 2002
- Anticardiolipin antibody testing: the need for standardizationArthritis & Rheumatism, 1987